Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Appeals Court Rehearing Rejected In Teva-GSK Skinny-Label Saga
Split Federal Circuit Refuses ‘En Banc’ Rehearing Of Labeling Carve-Out Case
Feb 14 2022
•
By
David Wallace
The appeals court refused to rehear the case on labelling carve-outs
More from Legal & IP
More from Generics Bulletin